Download
hypercalcemia treatment market analysis n.
Skip this Video
Loading SlideShow in 5 Seconds..
Hypercalcemia Treatment Market To Surpass US$ 28,060.0 Million By 2027 - Coherent Market Insights PowerPoint Presentation
Download Presentation
Hypercalcemia Treatment Market To Surpass US$ 28,060.0 Million By 2027 - Coherent Market Insights

Hypercalcemia Treatment Market To Surpass US$ 28,060.0 Million By 2027 - Coherent Market Insights

0 Vues Download Presentation
Télécharger la présentation

Hypercalcemia Treatment Market To Surpass US$ 28,060.0 Million By 2027 - Coherent Market Insights

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. HYPERCALCEMIA TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

  2. REPORT DESCRIPTION Hypercalcemia Treatment Market - Overview The most common cause of high calcium blood level is excess parathyroid hormone (PTH) released by the parathyroid glands. This can be attributed to enlargement of one or more parathyroid glands. Denosumab is a humanized monoclonal antibody used in hypercalcemia treatment. It inhibits the receptor activator of nuclear factor-κB ligand (RANKL). The global Hypercalcemia Treatment Market is estimated to account for US$ 10,696.6 Mn in terms of value in 2018 and is expected to reach US$ 28,060.0 Mn by the end of 2028. Global Hypercalcemia Treatment Market: Drivers Multiple myeloma is another prominent cause of high calcium levels in the blood. Therefore, high incidence of multiple myeloma is expected to propel growth of the global hypercalcemia treatment market. For instance, according to The American Cancer Society, around 32,270 new cases of multiple myeloma are expected to be diagnosed in 2020 in the U.S. (17,530 in men and 14,740 in women). Moreover, availability of appropriate drug therapy alternative over surgery is also expected to aid in growth of the market. Bisphosphonates normalise serum calcium levels in the blood in over 70% of patients with hypercalcaemia of malignancy within a period of 2–6 days of treatment. Bisphosphonates significantly reduce skeletal-related events (SREs). Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/hypercalcemia-treatment-market-3504 © Coherent market Insights. All Rights Reserved

  3. REPORT DESCRIPTION Global Hypercalcemia Treatment Market: Opportunities Accurate and definitive diagnosis of severe symptomatic hypercalcemia remains challenging. Etiological discussion of the non-malignant causes of parathyroid hormone- suppressed hypercalcemia can address the issue in this regard. Global Hypercalcemia Treatment Market: Restraints Distribution of hypercalcemia medicines face logistical challenges in terms of manufacturers locating appropriate channels such as independent pharmacies and drug stores to stock these drugs. This in turn is also expected to hamper the market growth. Key Takeaways: Bisphosphonates segment in the global hypercalcemia treatment market was valued at US$ 7,306.2 Mn in 2018 and is expected to reach US$ 19,798.3 Mn by 2027 at a CAGR of 11.7% during the forecast period. Bisphosphonates are standard of care in the management of cancer-associated hypercalcemia. The hospitals segment held dominant position in the global hypercalcemia treatment market in 2018, accounting for 39.0% share in terms of value, followed by clinics and Independent Pharmacy & Drug Stores, respectively. Patients primarily visit hospitals for treatment of diseases such as hypercalcemia. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/3504 © Coherent market Insights. All Rights Reserved

  4. REPORT DESCRIPTION North America region held dominant position in the global hypercalcemia treatment market in 2018, accounting for 45.5% share in terms of value, followed by Europe. Market Trends Synthetic implant can be used to identify hypercalcemia associated with cancer. For instance, in May 2018, researchers at ETH Zurich (Switzerland) and the University of Basel (Switzerland) reported an early warning system that consists of an encapsulated gene network integrated into human body cells implanted under the skin, which monitors blood calcium levels. Lithium causes long term thyroid problems and can adversely impact the parathyroid glands. Moreover, lithium-induced hyperparathyroidism is four times more likely to occur in women than in men. Global Hypercalcemia Treatment Market: Competitive Landscape Major players operating in the global hypercalcemia treatment market include, Bayer Pharma AG, Sun Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Amgen Inc., Novartis AG, Dr. Reddy’s Laboratories Ltd., Cipla Inc., and XOMA Corporation. Global Hypercalcemia Treatment Market: Key Development January 2019: Teva Pharmaceutical Industries Limited announced that it has resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl product Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3504 © Coherent market Insights. All Rights Reserved

  5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

  6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

  7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

  8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved